Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine for Breast MRI Screening: a Meta-analysis |
Yang, Xiao-Ping
(Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University)
Han, Yue-Dong (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ye, Jian-Jun (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Chen, Gang (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Luo, Ying (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ma, Hong-Xia (Department of Radiology, General Hospital of Lanzhou Command PLA) Yu, Xue-Wen (Department of Radiology, General Hospital of Lanzhou Command PLA) Niu, Juan-Qin (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Ren, Fang-Yuan (Department of Radiology, the First Hospital of Medical College of Xi'an Jiaotong University) Guo, You-Ming (Department of Radiology, General Hospital of Lanzhou Command PLA) |
1 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA: a Cancer J Clin, 62, 10-29. DOI ScienceOn |
2 | Stomper PC, Herman S, Klippenstein DL, et al (1995). Suspect Breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated. Radiology, 197, 387-95. DOI |
3 | Whiting PF, Weswood ME, Rutjes AW, et al (2006). Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol, 6, 9. DOI ScienceOn |
4 | Zamora J, Abraira V, Muriel A, et al (2006). Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol, 6, 31. DOI |
5 | Luciani M, Pediconi F, Telesca M, et al (2011). Incidental enhancing lesions found on preoperative breast MRI: management and role of second-look ultrasound. La Radiologia Medica, 116, 886-904. DOI |
6 | Martincich L, Faivre-Pierret M, Zechmann C M, et al (2011). Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for breast MR imaging (DETECT Trial). Radiology, 258, 396-408. DOI ScienceOn |
7 | Pediconi F, Catalano C, Occhiato R, et al (2005). breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine1. Radiology, 237, 45-56. DOI ScienceOn |
8 | Pediconi F, Catalano C, Roselli A, et al (2007). Contrastenhanced MR Mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions1. Radiology, 243, 670-80. DOI ScienceOn |
9 | Sardanelli F, Iozzelli A, Fausto A, et al (2005). Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity1. Radiology, 235, 791-7. DOI ScienceOn |
10 | Saslow D, Boetes C, Burke W, et al (2007). American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA: a cancer journal for clinicians, 57, 75-89. DOI ScienceOn |
11 | Semelka RC, Hernandes MdA, Stallings CG, Castillo M (2012). Objective evaluation of acute adverse events and image quality of gadolinium-based contrast agents (gadobutrol and gadobenate dimeglumine) by blinded evaluation. Pilot study. Magn Reson Imag, 31, 96-101. |
12 | Knopp MV, Bourne MW, Sardanelli F, et al (2003). Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Am J Roentgenol, 181, 663-76. DOI ScienceOn |
13 | Helbich TH, Becherer A, Trattnig S, et al (1997). Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography. Radiology, 202, 421-9. DOI |
14 | Kawashima H, Tawara M, Suzuki M, et al (2001). Effectiveness of dynamic MRI for diagnosing pericicatricial minimal residual breast cancer following excisional biopsy. Eur J Radiol, 40, 2-9. DOI ScienceOn |
15 | Kneeshaw P, Lowry M, Manton D, et al (2006). Differentiation of benign from malignant breast disease associated with screening detected microcalcifications using dynamic contrast enhanced magnetic resonance imaging. The Breast, 15, 29-38. DOI ScienceOn |
16 | Kriege M, Brekelmans CT, Boetes C, et al (2004). Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. New Engl J Med, 351, 427-37. DOI ScienceOn |
17 | Kuhl CK (2007). Current Status of Breast MR Imaging Part 2. Clinical Applications1. Radiology, 244, 672-91. DOI ScienceOn |
18 | Lehman CD, Blume JD, Weatherall P, et al (2005). Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer, 103, 1898-905. DOI ScienceOn |
19 | Alamo L, Fischer U (2001). Contrast-enhanced color doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI. Eur Radiol, 11, 970-7. DOI ScienceOn |
20 | Boetes C, Veltman J, van Die L, et al (2004). The role of MRI in invasive lobular carcinoma. Breast Cancer Res Tr, 86, 31-7. DOI |
21 | Goerres GW, Michel SC, Fehr MK, et al (2003). Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol, 13, 1635-44. DOI ScienceOn |
22 | Fischer U, Kopka L, Grabbe E (1999). Breast carcinoma: Effect of preoperative contrast-enhanced mr imaging on the therapeutic approach1. Radiology, 213, 881-8. DOI ScienceOn |
23 | Fobben ES, Rubin CZ, Kalisher L, et al (1995). Breast MR imaging with commercially available techniques: radiologicpathologic correlation. Radiology, 196, 143-52. DOI |
24 | Woodhams R, Kakita S, Hata H, et al (2010). Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging-comparison with contrast-enhanced MR imaging and pathologic findings1. Radiology, 254, 357-66. DOI ScienceOn |
25 | Pediconi F, Catalano C, Padula S, et al (2008). Contrastenhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. Am J Roentgenol, 191, 1339-46. DOI ScienceOn |
26 | Fenlon HM, Phelan NC, O'Sullivan P, et al (1997). Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography. Radiology, 205, 214-20. DOI |
![]() |